background_placeholder
pleural mesothelioma

Articles about pleural mesothelioma

     
Kies meer

Trending
Er zijn @count nieuwe artikelen
Tuesday, March 29, 2022 - 02:00 - In Trending
[Articles] Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Tuesday, March 29, 2022 - 02:00 - In Trending
[Comment] ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma
Saturday, March 19, 2022 - 09:24 - In Trending
Prognostic impact of inflammation in malignant pleural mesothelioma: a large-scale analysis of consecutive patients
Tuesday, February 1, 2022 - 10:16 - In Trending
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Tuesday, November 16, 2021 - 12:00 - In Trending
“Immune checkpoint inhibitor therapy for malignant pleural mesothelioma”
Monday, November 8, 2021 - 21:00 - In Trending
Immunotherapy-chemotherapy treatment coupled with in-depth genomic analyses leads to improved survival for patients with mesothelioma
Friday, July 23, 2021 - 02:00 - In Trending
[Correspondence] Heterogeneity of treatment effects in malignant pleural mesothelioma
Friday, July 23, 2021 - 02:00 - In Trending
[Correspondence] Heterogeneity of treatment effects in malignant pleural mesothelioma – Authors' reply

Kies uw tags

triple negative breast cancer
multipel myeloom
neuroendocrine carcinoma
hairy cell leukemia
meningioma
brain tumour
polycythemia vera
mast cell leukemia
hyperthyroidism
NSCLC